Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Neoplasms of the CNS

Free Subscription 06.04.2026 2 AJNR Am J Neuroradiol 2 Childs Nerv Syst 1 J Natl Cancer Inst 1 J Neurol 9 J Neurooncol 5 J Neurosurg 4 Neuro Oncol 3 Neuroradiology 3 Neurosurgery 1 Oncogene 2 PLoS One 2 Radiol Imaging Cancer

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. NOCERA G, Sanvito F, Yao J, Kryukov I, et al
   Influence of post-bolus acquisition duration on estimated percentage of signal recovery from dynamic susceptibility contrast MRI in brain tumors.
   AJNR Am J Neuroradiol. 2026 Apr 2:ajnr.A9310. doi: 10.3174/ajnr.A9310.
   PubMed         Abstract available
   
   
2. WARSTADT MB, Richards TJ, Shah LM, Kohler ME, et al
   Glioneuronal and Neuronal Tumors in Adults: World Health Organization 2021 Imaging and Molecular Updates.
   AJNR Am J Neuroradiol. 2026;47:867-878.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

3. CHENG Z, Ong SH, Suntoro VA, Cheng K, et al
   Long-term follow-up of dysembryoplastic neuroepithelial tumour (DNET) with recurrent bleeds: a case report and review of literature.
   Childs Nerv Syst. 2026;42:146.
   PubMed         Abstract available
   
   
4. AL SALMI HZ, Al-Saadi HR, Al Maskari AY, Al Maskari SY, et al
   Bridging surgery and radiotherapy: the role of stereotactic radiosurgery in pediatric brain tumor care.
   Childs Nerv Syst. 2026;42:139.
   PubMed         Abstract available
   
   

   
   J Natl Cancer Inst

5. GROBMAN B, Lamba N, Catalano PJ, Tanguturi SK, et al
   Survival and treatment among older patients with brain metastases: a Population-Based study.
   J Natl Cancer Inst. 2026 Mar 30:djag098. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Neurol

6. NISHII S, Akatani R, Shiroma K, Takeda R, et al
   Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma.
   J Neurol. 2026;273:248.
   PubMed         Abstract available
   
   

   
   J Neurooncol

7. KIM Y, Seo Y, Kim J
   Novel cilengitide derivatives suppress migration and invasion of temozolomide-resistant glioblastoma cells via MAPK/Akt pathway inhibition.
   J Neurooncol. 2026;177:77.
   PubMed        
   
   
8. SHIN CJ, Mahammedi A, Massoud TF
   Intraventricular meningiomas show size-dependent increases in peak ASL-MRI perfusion reflecting vascular heterogeneity.
   J Neurooncol. 2026;177:89.
   PubMed        
   
   
9. OWENS GC, Contreras EM, Kienzler JC, Treger J, et al
   Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant.
   J Neurooncol. 2026;177:88.
   PubMed        
   
   
10. GRIGORIAN J, Chandler KE, Miller K, Mehta A, et al
    Young adults with primary brain tumors: predictors of referral to a fertility specialist for fertility preservation counseling and the impact on tumor treatment.
    J Neurooncol. 2026;177:87.
    PubMed        
    
    
11. DUFAULT ME, Akhavan-Sigari A, Pachon-Londono MJ, Olson VA, et al
    From barrier to bridge: a scoping review on the methods, clinical efficacy, and safety of blood-brain barrier disruption in treating high-grade glioma.
    J Neurooncol. 2026;177:86.
    PubMed        
    
    
12. BALDINI C, Cassier PA, Delord JP, Simonelli M, et al
    Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study.
    J Neurooncol. 2026;177:85.
    PubMed        
    
    
13. FUKAMI S, Akimoto J, Nagai K, Nakajima N, et al
    Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes.
    J Neurooncol. 2026;177:84.
    PubMed         Abstract available
    
    
14. LESKINEN S, Coelho A, Mittelman L, Haile H, et al
    Low-energy X-ray intraoperative radiotherapy for brain metastases: a systematic review of efficacy and safety.
    J Neurooncol. 2026;177:81.
    PubMed        
    
    
15. RONCELLI F, Snider S, Boselli D, De Domenico P, et al
    Correction to: Prognostic relevance and cytokine correlates of peripheral immune subpopulations in newly diagnosed glioblastoma.
    J Neurooncol. 2026;177:78.
    PubMed        
    
    

    
    J Neurosurg

16. JACQUESSON T, Goichot L, Beaumont A, Frindel C, et al
    High-resolution T2-weighted MRI versus tractography to predict cranial nerve anatomy in skull base tumors: a retrospective 132-case series.
    J Neurosurg. 2026 Jan 23:1-8. doi: 10.3171/2025.9.JNS243271.
    PubMed         Abstract available
    
    
17. RINDLER RS, Dang DD, Kumar R, Herndon J, et al
    Association of standard postoperative day 1 discharge following endonasal surgery for pituitary adenoma with lower complication rates and unplanned medical care.
    J Neurosurg. 2026;144:929-936.
    PubMed         Abstract available
    
    
18. SHAH I, Gomez D, Cote DJ, Briggs RG, et al
    Utility of standardized T2-weighted MRI intensity ratio for prediction of pituitary macroadenoma consistency.
    J Neurosurg. 2026 Jan 16:1-10. doi: 10.3171/2025.8.JNS25387.
    PubMed         Abstract available
    
    
19. PECORARI IL, Lally A, Reynolds JA, Ghosh SR, et al
    Relationship between race, socioeconomic status, and prolonged hospital length of stay after meningioma resection in the Bronx, New York.
    J Neurosurg. 2026 Mar 27:1-10. doi: 10.3171/2025.10.JNS241452.
    PubMed         Abstract available
    
    
20. WONG CE, Chang Y, Tien CH, Perng PS, et al
    Predictors of neurological outcomes after resection of brain metastases: a cohort study and classification for patient selection.
    J Neurosurg. 2026 Apr 3:1-10. doi: 10.3171/2025.11.JNS251798.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

21. TRINGALE KR, Jenabi M, Kohli J, Jackson C, et al
    Functional Neuroimaging Biomarkers of Impaired Neurocognition After Proton Beam Radiotherapy for Brain Tumors in Pediatric Patients: A Prospective Trial.
    Neuro Oncol. 2026 Mar 30:noag072. doi: 10.1093.
    PubMed         Abstract available
    
    
22. TAKEI J, Furudate K, Nagaoka-Kamata Y, Iwaloye O, et al
    Exploring the immune environment of glioblastoma in humanized mouse models.
    Neuro Oncol. 2026 Mar 30:noag073. doi: 10.1093.
    PubMed         Abstract available
    
    
23. LI C, Chen M, Guo S, Ma Y, et al
    PTBP1 knockdown reprograms glioma stem cells into neuronal-like cells and suppresses tumorigenesis via the DUSP5-ERK1/2 signaling pathway.
    Neuro Oncol. 2026 Mar 28:noag068. doi: 10.1093.
    PubMed         Abstract available
    
    
24. BAMELIS AS, Metselaar DS, Sie M, Lootens T, et al
    Attract to kill: Exploring the potential of motility trapping as a novel treatment strategy for high-grade gliomas.
    Neuro Oncol. 2026 Mar 28:noag067. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

25. REYES JS, Estupinan-Pepinosa DF, Leal-Giraldo SI, Cordoba-Gallego MF, et al
    Artificial intelligence and radiomics for pediatric brain tumor classification and molecular characterization: a systematic review.
    Neuroradiology. 2026 Mar 27. doi: 10.1007/s00234-026-03976.
    PubMed         Abstract available
    
    
26. KHALAF A, Naya L, Flynt L, Surasi DS, et al
    [(18)F]DASA-23 PET/MRI evaluation in newly-diagnosed and recurrent high-grade glioma.
    Neuroradiology. 2026 Apr 1. doi: 10.1007/s00234-026-03956.
    PubMed        
    
    
27. MAHMOODI AL, Smolders L, Landers MJF, Rutten GJM, et al
    Objective characterization of displacement of the frontal aslant tract in low-grade glioma: a quantitative tractography study.
    Neuroradiology. 2026 Apr 1. doi: 10.1007/s00234-026-03968.
    PubMed        
    
    

    
    Neurosurgery

28. PARK M, Weiss H, Harake ES, Fang C, et al
    Anatomic Predilection of Isocitrate Dehydrogenase-Mutant Gliomas: A Multi-Institutional Spatial Analysis.
    Neurosurgery. 2026 Apr 3. doi: 10.1227/neu.0000000000004019.
    PubMed         Abstract available
    
    
29. MENNA G, Al-Adli NN, Gerritsen JKW, Cha S, et al
    Impact of Postoperative Diffuse-Weighted Imaging Rim Restriction on Neurological Outcomes After Resection of Newly Diagnosed Isocitrate Dehydrogenase-Wildtype Glioblastoma.
    Neurosurgery. 2026 Mar 31. doi: 10.1227/neu.0000000000004012.
    PubMed         Abstract available
    
    
30. MAAROUF NI, Reinecke D, Smith A, Markert JE, et al
    Natural Language Processing Methods Automate Molecular Marker Extraction From Glioma Pathology Reports.
    Neurosurgery. 2026 Mar 27. doi: 10.1227/neu.0000000000004000.
    PubMed         Abstract available
    
    

    
    Oncogene

31. ZHANG Y, Xue Z, Zhang N, Zhu Y, et al
    Correction: The multifunctional RNA helicase DDX39A drives glioblastoma progression by modulating WISP1 alternative splicing that induces an immunosuppressive macrophage polarization.
    Oncogene. 2026 Apr 1. doi: 10.1038/s41388-026-03756.
    PubMed        
    
    

    
    PLoS One

32. BROOKS AM, Vornoli A, Kovi RC, Ton TVT, et al
    Correction: Genetic profiling of rat gliomas and cardiac schwannomas from life-time radiofrequency radiation exposure study using a targeted next-generation sequencing gene panel.
    PLoS One. 2026;21:e0346498.
    PubMed         Abstract available
    
    
33. AL-SHAMKHI N, Eden Engstrom B, Rask E, Anderzen-Carlsson A, et al
    The impact of a non-functioning pituitary adenoma on life - A qualitative study of patients' experiences.
    PLoS One. 2026;21:e0345909.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

34. WU J, Billot B, Zhao F, Li J, et al
    TumorSynth: Integrated Brain Tumor and Tissue Segmentation on Brain MRI Scans of Any Resolution and Contrast.
    Radiol Imaging Cancer. 2026;8:e250222.
    PubMed         Abstract available
    
    
35. LASOCKI A, Thust SC, McArthur GA
    A Framework for MRI Characterization of Intracranial Metastatic Disease.
    Radiol Imaging Cancer. 2026;8:e250627.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum